Delivery Order SPE2DB20D1100-SPE2DB25FD7A9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Nayzilam 5 mg nasal sprays, with a ceiling value of $1,043.25. This is a firm fixed price, competitively awarded contract with no set-aside designation. The delivery order is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. This award represents a child contract under...
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,043.25 for Nayzilam 5 mg nasal sprays on July 29, 2025, with completion scheduled for July 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Nayzilam 5 mg nasal sprays under a firm fixed-price contract valued at $1,043.25, with an ultimate completion date of July 31, 2025. This non-set-aside contract represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $3,477.50 delivery order to AmerisourceBergen Drug Corp for Nayzilam 5 mg nasal sprays under a firm fixed price contract structure. The award was issued on July 28, 2025, with a completion date of July 29, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location. This delivery order is executed as a child contract under...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Nayzilam 5 mg nasal sprays. The contract has a firm fixed price, with a ceiling value of $2,434.06, and a period of performance through May 6, 2025. The contract is not set aside for any specific type of business. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $2,558.31 from the Defense Logistics Agency for the supply of Nayzilam 5 mg nasal spray. The contract was awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, under firm fixed pricing with no set-aside designation. This delivery order represents a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $418.21 to Amerisourcebergen Drug Corporation for 4561366185 Nayzilam 5 mg nasal sprays. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products to the specified location in Conshohocken, Pennsylvania by the end date of June 29, 2023 under the terms of this order. The parent company, Amerisourcebergen Corporation, will provide support through its Corporate...
- The Defense Logistics Agency Troop Support Medical awarded a $1,483.96 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 5 mg Nayzilam nasal spray units. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance from August 31, 2023 through September 1, 2023. As the DLA is responsible for worldwide logistics support of the Department of Defense, this delivery order was likely placed to...
- The Defense Logistics Agency Troop Support Medical awarded a $336,130 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 5,000 boxes of 5 mg Nayzilam nasal spray. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The delivery order has a period of performance from August 25, 2023 through August 28, 2023. Nayzilam is an FDA-approved nasal spray used for treatment of seizure clusters, indicating this delivery order is likely intended...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $336.13 to Amerisourcebergen Drug Corporation for 4561904184 Nayzilam 5 mg nasal sprays. As the prime contractor, Amerisourcebergen will deliver the requested pharmaceutical products to a facility in Conshohocken, Pennsylvania under a one-day period of performance from August 22 to August 23, 2023. The Defense Logistics Agency functions to support America's armed forces by procuring their necessary supplies and...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD7A9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Nayzilam 5 mg nasal sprays, with a ceiling value of $1,043.25. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and represents no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical procurement vendor. The order will be performed at the company's Corporate Office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Nayzilam, a seizure medication administered via nasal spray, represents one element of the critical medical commodities the contractor supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 7/29/25 |